New insights into embryonic blood development could pave the way for targeted treatments for a rare childhood leukaemia
Research led by Emanuele Azzoni at the HEVA Research Laboratory sheds light on the earliest stages of blood cell formation, offering new clues to understand juvenile myelomonocytic leukaemia



